Opportunistic infections: stemming the tide.
MacDougall
D S
DS
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D019380:Anti-HIV Agents / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D002177:Candidiasis / Q000150:complications / Q000517:prevention & control; D003586:Cytomegalovirus Infections / Q000150:complications / Q000517:prevention & control; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006566:Herpesviridae Infections / Q000150:complications / Q000517:prevention & control; D006801:Humans; D008297:Male; D015270:Mycobacterium avium-intracellulare Infection / Q000150:complications / Q000517:prevention & control; D027383:Papillomaviridae / Q000302:isolation & purification; D011020:Pneumonia, Pneumocystis / Q000150:complications / Q000517:prevention & control; D014376:Tuberculosis / Q000150:complications / Q000517:prevention & control; D014412:Tumor Virus Infections / Q000150:complications / Q000517:prevention & control / Q000821:virology; D019562:Viral Load
D019380:Anti-HIV Agents